With the aim of discovering potential cytotoxic agents, a new series of substituted 4-chromenes were synthesized in three steps starting from the readily available 4-chromanone 3. Alkylation of compound 3 afforded alkyne 4-chromanone 5, which on subsequent cyclization provided pyranochromene 10. Reaction of compounds 5 and 10 with Grignard reagents yielded the desired compounds 7, 8a-d/9a-9d, 12a-b and 14a-c/15a-c. The synthesized compounds were evaluated for their cytotoxic activity on three different cell lines, namely HT29, T47D and L929 and most of them were shown to be relatively good with IC 50 = 100-130 µM. Among them, 14b/15b and 8c/9c were the most potent ones with the IC 50 =92.28 ± 16.84 (on HT29) and 94.48 ± 15.37 µM (on T47D), respectively.
Introduction
Chromenes are structurally simple compounds belonging to a large class of molecules known as benzopyranes and chroman-4-one moiety is an integral part of many natural products. These compounds and related derivatives have diverse biological activities, including antitumor, leishmanicidal, bacteriostatic that makes these compounds attractive for further backbone derivatisation and screening as a novel therapeutic agent. [1] [2] [3] Chroman-4-one derivatives have also drawn much attention due to their anti-human-immunodeficiency-virus (HIV-1) activity. 4 Recently, several new naturally occurring chromenes, including Licuformodiol A, B have been isolated from the cytotoxic chloroform-soluble fraction of Ficus formosana and carpachromene exhibited significant cytotoxicity against HepG2, PLC/RRF/5 and Raji cell lines in vitro. 5 Furthermore, considerable interest has recently been shown toward pharmacological activity exhibited by naphtopyrane derivatives which have been isolated from liches plant. 6 Lichen 4H-4-Chromenone derivatives have also shown to be inhibitors of protein kinases. 7 4H-Chromene-3-carboxylate was found to induce Cytochrome c release from the mitochondria of intact cells, which Cytochrome c release is a central step in the apoptosis induced by many death stimulations. 8 More recently, some amino 4H-chromenes were found to induce nuclear fragmentation and PARP cleavage as well as to arrest cells at the G(2)M stage and to induce apoptosis. In a search to find new cytotoxic agents structurally related to 2,2-dimethyl-2H-chromenes (Glyasperin, Seselin, Acromycine, Fig.1 ), herein we report the synthesis and cytotoxic activity of new chromene derivatives as potential anticancer agents. of the alcohol 6 to the corresponding olefin 7 was accomplished by acidic dehydration in refluxing 1N HCl. Similarly reaction of substituted benzylmagnesium chloride with compound 5 followed by dehydration gave a mixture of exo (8a _ d) and endo (9a H-NMR, observation of a doublet at 2.50 to 2.65 ppm (3-CH 2 of compound 8) and a singlet at 3.65 to 3.80 ppm (benzylic CH 2 of compound 9) showed the existence of both endo and exo isomers respectively, in the ratio of the 56:44 to 60:40. Moreover, the exo product appeared to be a mixture of E and Z steroisomers which were assigned based on the anisotropic effect of substituted phenyl ring on H 5 of the Z isomer. In the E isomer H 5 of compound 8 appeared as a doublet at 7.50 to 7.55 (J= 8. 5 Hz) . However in Z isomer, it appeared at 7.47 to 7.53 ppm (J = 8.5 Hz). The ratio of E to Z sterioisomers of compounds 8a-d were measured to be 95:5 to 65:35. The configuration of the E isomer as a major product was confirmed through 2D NOESY NMR spectroscopy and the assignment of stereochemistry of compound 8a is consisted with the observed strong cross peak between H 5 and vinylic-H (Ar-CH=C) and relatively weak cross peak between H 3 and ortho-H phenyl ring. In addition, in 13 C-NMR the 3-CH 2 of exo and benzylic CH 2 Culture mediums containing DMSO in concentration equal to those incubations treated with the tested compound served as control. Cell incubation was then kept at 37° C under an atmosphere of 95% air: 5% CO 2 . The response of cells to chromene derivatives was evaluated by determining the cell survival using MTT assay after 24 h. 16 Survival was scored by comparing treated cells with the tested compounds to untreated cells (control) and is expressed as percentage of cell survival. IC 50 of these compounds in three cancer cell lines in comparison to methotreaxate as a reference drug is summarized in Table 1 . As shown in Table 1 , for HT29 the most active compound was 14b/15b with IC 50 =92.28±16.84 µM and compounds 12a, 12b, 8a/9a and 8c/9c with similar activities were more active than the rest. In T47D the most active compound was 8c/9c with IC 50 =94.48±15.37 µM and in L929 several compounds had activities in the range of 103.50±6.16 to 109.43±4.35.
Finally, compounds 8c/9c and 14b/15b showed relatively good activities in all tested cell lines.
In conclusion, through this study we have synthesized several chromenes ( 
4-(4-Chlorophenyl)-2,2-dimethyl-7-(2-methylbut-3-yn-2-yloxy)-2H-chromene (7).
To a stirred solution of 5 (0.2 g, 0.77 mmol), in dry ether (3 mL) was added 4-chlorophenylmagnesium bromide (2.5 mL, 2 mmol, 0.8 M) under argon. The resulting mixture was stirred and refluxed for 18 h. After cooling, the organic phase was washed with 1N HCl (3×5 mL). The solvent was removed under reduced pressure to give an oil of crude alcohol 6. To this oily residue was added 2N HCl (5 mL) and refluxed for 3 hours. After cooling, it was extracted with ethyl acetate (3×10 mL), washed with saturated aqueous NaHCO 3 and dried (Na 2 SO 4 ). After concentration, the residue was purified by flash column chromatography (silica gel= 10 g, hexane / 9a-d, 12a−b and 14/15a-c) were prepared similarly. Chlorobenzylidene)-3,4-dihydro-2,2-dimethyl-7-(2-methylbut-3-yn-2-yloxy)-2H-chromene (8a-exo) and 4-(4-Chlorobenzyl)-7-(2-methylbut-3-yn-2-yloxy)-2,2-dimethyl-2H-chromene (9a-endo) 4-(2-Chlorobenzylidene)-3,4-dihydro-2,2-dimethyl-7-(2-methylbut-3-yn-2-yloxy)-2H-chromene (8c-exo) and 4-(2-Chlorobenzyl)-7-(2-methylbut-3-yn-2-yloxy)-2,2-dimethyl-2H-chromene (9c-endo) 
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4-(3-Chlorobenzylidene)-3,4-dihydro-2,2-dimethyl-7-(2-methylbut-3-yn-2-yloxy)-2H-chromene (8b-exo) and 4-(3-Chlorobenzyl)-7-(2-methylbut-3-yn-2-yloxy)-2,2-dimethyl-2H-chromene (9b-endo
